BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Golpich M, Rahmani B, Mohamed Ibrahim N, Dargahi L, Mohamed Z, Raymond AA, Ahmadiani A. Preconditioning as a potential strategy for the prevention of Parkinson's disease. Mol Neurobiol 2015;51:313-30. [PMID: 24696268 DOI: 10.1007/s12035-014-8689-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Lee Y, Kim M, Lee J. Neuroprotective strategies to prevent and treat Parkinson’s disease based on its pathophysiological mechanism. Arch Pharm Res 2017;40:1117-28. [DOI: 10.1007/s12272-017-0960-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
2 Ba Q, Cui C, Wen L, Feng S, Zhou J, Yang K. Schisandrin B shows neuroprotective effect in 6-OHDA-induced Parkinson's disease via inhibiting the negative modulation of miR-34a on Nrf2 pathway. Biomed Pharmacother 2015;75:165-72. [PMID: 26282218 DOI: 10.1016/j.biopha.2015.07.034] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
3 Onyango IG, Bennett JP, Stokin GB. Regulation of neuronal bioenergetics as a therapeutic strategy in neurodegenerative diseases. Neural Regen Res 2021;16:1467-82. [PMID: 33433460 DOI: 10.4103/1673-5374.303007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Golpich M, Amini E, Mohamed Z, Azman Ali R, Mohamed Ibrahim N, Ahmadiani A. Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment. CNS Neurosci Ther 2017;23:5-22. [PMID: 27873462 DOI: 10.1111/cns.12655] [Cited by in Crossref: 200] [Cited by in F6Publishing: 177] [Article Influence: 33.3] [Reference Citation Analysis]
5 Shanesazzade Z, Peymani M, Ghaedi K, Nasr Esfahani MH. miR-34a/BCL-2 signaling axis contributes to apoptosis in MPP+ -induced SH-SY5Y cells. Mol Genet Genomic Med 2018;6:975-81. [PMID: 30221494 DOI: 10.1002/mgg3.469] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
6 Dar KB, Bhat AH, Amin S, Reshi BA, Zargar MA, Masood A, Ganie SA. Elucidating Critical Proteinopathic Mechanisms and Potential Drug Targets in Neurodegeneration. Cell Mol Neurobiol 2020;40:313-45. [PMID: 31584139 DOI: 10.1007/s10571-019-00741-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
7 Weilnau JN, Carcella MA, Miner KM, Bhatia TN, Hutchison DF, Pant DB, Nouraei N, Leak RK. Evidence for cross-hemispheric preconditioning in experimental Parkinson's disease. Brain Struct Funct 2018;223:1255-73. [PMID: 29103154 DOI: 10.1007/s00429-017-1552-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zhao Q, Tian Z, Zhou G, Niu Q, Chen J, Li P, Dong L, Xia T, Zhang S, Wang A. SIRT1-dependent mitochondrial biogenesis supports therapeutic effects of resveratrol against neurodevelopment damage by fluoride. Theranostics 2020;10:4822-38. [PMID: 32308752 DOI: 10.7150/thno.42387] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
9 Wang Z, Sun L, Jia K, Wang H, Wang X. miR-9-5p modulates the progression of Parkinson's disease by targeting SIRT1. Neurosci Lett 2019;701:226-33. [PMID: 30826419 DOI: 10.1016/j.neulet.2019.02.038] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
10 Pourbadie HG, Sayyah M, Khoshkholgh-Sima B, Choopani S, Nategh M, Motamedi F, Shokrgozar MA. Early minor stimulation of microglial TLR2 and TLR4 receptors attenuates Alzheimer's disease-related cognitive deficit in rats: behavioral, molecular, and electrophysiological evidence. Neurobiol Aging 2018;70:203-16. [PMID: 30031930 DOI: 10.1016/j.neurobiolaging.2018.06.020] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 7.3] [Reference Citation Analysis]
11 Sa F, Zhang LQ, Chong CM, Guo BJ, Li S, Zhang ZJ, Zheng Y, Hoi PM, Lee SMY. Discovery of novel anti-parkinsonian effect of schisantherin A in in vitro and in vivo. Neuroscience Letters 2015;593:7-12. [DOI: 10.1016/j.neulet.2015.03.016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
12 Salimian N, Peymani M, Ghaedi K, Nasr Esfahani MH. Modulation in miR-200a/SIRT1axis is associated with apoptosis in MPP+-induced SH-SY5Y cells. Gene 2018;674:25-30. [PMID: 29936262 DOI: 10.1016/j.gene.2018.06.061] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]